AAAAAA

   
Results: 1-25 |
Results: 25
PROGNOSTIC IMPACT OF AMENORRHEA AFTER ADJUVANT CHEMOTHERAPY IN PREMENOPAUSAL BREAST-CANCER PATIENTS WITH AXILLARY NODE INVOLVEMENT - RESULTS OF THE INTERNATIONAL BREAST-CANCER STUDY-GROUP (IBCSG) TRIAL-VI
Authors: PAGANI O ONEILL A CASTIGLIONE M GELBER RD GOLDHIRSCH A RUDENSTAM CM LINDTNER J COLLINS J CRIVELLARI D COATES A CAVALLI F THURLIMANN B SIMONCINI E FEY M PRICE K SENN HJ
Citation: O. Pagani et al., PROGNOSTIC IMPACT OF AMENORRHEA AFTER ADJUVANT CHEMOTHERAPY IN PREMENOPAUSAL BREAST-CANCER PATIENTS WITH AXILLARY NODE INVOLVEMENT - RESULTS OF THE INTERNATIONAL BREAST-CANCER STUDY-GROUP (IBCSG) TRIAL-VI, European journal of cancer, 34(5), 1998, pp. 632-640
DOSE-FINDING STUDY OF HIGH-DOSE EPIRUBICIN (E) AND DOCETAXEL (D) AS FIRST-LINE CHEMOTHERAPY IN ADVANCED BREAST-CANCER (ABC)
Authors: PAGANI O SESSA C MARTINELLI G CRIVELLARI D GOLDHIRSCH A
Citation: O. Pagani et al., DOSE-FINDING STUDY OF HIGH-DOSE EPIRUBICIN (E) AND DOCETAXEL (D) AS FIRST-LINE CHEMOTHERAPY IN ADVANCED BREAST-CANCER (ABC), European journal of cancer, 34, 1998, pp. 37-37
HIGH-DOSE EPIRUBICIN AND CYCLOPHOSPHAMIDE (EC) VS CYCLOPHOSPHAMIDE, METHOTREXATE, FLUOROURACIL (CMF) AS ADJUVANT CHEMOTHERAPY IN HIGH-RISK PREMENOPAUSAL BREAST-CANCER PATIENTS (PTS) - A PROSPECTIVE RANDOMIZED TRIAL
Authors: GALLIGIONI E CETTO G NASCIMBEN O BUONADAONA A CRIVELLARI D MOLINO A VERONESI A GRAIFF C BARNI S PUCCETTI C FERRAZZI E RECALDIN E SAVA C SARACCHINI S SACCO C
Citation: E. Galligioni et al., HIGH-DOSE EPIRUBICIN AND CYCLOPHOSPHAMIDE (EC) VS CYCLOPHOSPHAMIDE, METHOTREXATE, FLUOROURACIL (CMF) AS ADJUVANT CHEMOTHERAPY IN HIGH-RISK PREMENOPAUSAL BREAST-CANCER PATIENTS (PTS) - A PROSPECTIVE RANDOMIZED TRIAL, European journal of cancer, 34, 1998, pp. 84-84
DOSE-FINDING STUDY OF HIGH-DOSE EPIRUBICIN (E) AND DOCETAXEL (D) AS FIRST-LINE CHEMOTHERAPY IN ADVANCED BREAST-CANCER (ABC)
Authors: PAGANI O SESSA C VANDENBULCKE T MARTINELLI G ZAMPINO G NOLE F ZIMATORE M LOCATELLI M CRIVELLARI D BUONADONNA A THURLIMANN B HESS D BORNER M BAUER J RIGGI M RIVA A GOLDHIRSCH A
Citation: O. Pagani et al., DOSE-FINDING STUDY OF HIGH-DOSE EPIRUBICIN (E) AND DOCETAXEL (D) AS FIRST-LINE CHEMOTHERAPY IN ADVANCED BREAST-CANCER (ABC), Annals of oncology, 9, 1998, pp. 74-74
PALLIATIVE TREATMENT WITH 5-FU CONTINUOUS-INFUSION (CI) IN PATIENTS WITH METASTATIC BREAST-CANCER RESISTANT TO CONVENTIONAL THERAPIES
Authors: CRIVELLARI D BUONADONNA A MAGRI MD DECICCO M FERLANTE MA VERONESI A
Citation: D. Crivellari et al., PALLIATIVE TREATMENT WITH 5-FU CONTINUOUS-INFUSION (CI) IN PATIENTS WITH METASTATIC BREAST-CANCER RESISTANT TO CONVENTIONAL THERAPIES, Annals of oncology, 9, 1998, pp. 101-101
TAMOXIFEN AS ADJUVANT AFTER SURGERY FOR BREAST-CANCER AND TAMOXIFEN OR PLACEBO AS CHEMOPREVENTION IN HEALTHY WOMEN - DIFFERENT COMPLIANCE WITH TREATMENT
Authors: VERONESI A PIZZICHETTA MA FERLANTE MA ZOTTAR M MAGRI MD CRIVELLARI D FOLADORE S
Citation: A. Veronesi et al., TAMOXIFEN AS ADJUVANT AFTER SURGERY FOR BREAST-CANCER AND TAMOXIFEN OR PLACEBO AS CHEMOPREVENTION IN HEALTHY WOMEN - DIFFERENT COMPLIANCE WITH TREATMENT, Tumori, 84(3), 1998, pp. 372-375
LOW INCIDENCE OF BRCA1 MUTATIONS AMONG ITALIAN FAMILIES WITH BREAST AND OVARIAN-CANCER
Authors: SANTAROSA M VIEL A DOLCETTI R CRIVELLARI D MAGRI MD PIZZICHETTA MA TIBILETTI MG GALLO A TUMOLO S DELTIN L BOIOCCHI M
Citation: M. Santarosa et al., LOW INCIDENCE OF BRCA1 MUTATIONS AMONG ITALIAN FAMILIES WITH BREAST AND OVARIAN-CANCER, International journal of cancer, 78(5), 1998, pp. 581-586
DOSE-FINDING STUDY OF HIGH-DOSE EPIRUBICIN (E) AND DOCETAXEL (T) AS FIRST LINE CHEMOTHERAPY IN ADVANCED BREAST-CANCER (ABC)
Authors: PAGANI O AAPRO M MARTINELLI G BAUER J BORNER M CRIVELLARI D THURLIMANN B VANDENBULCKE T GOLDHIRSCH A
Citation: O. Pagani et al., DOSE-FINDING STUDY OF HIGH-DOSE EPIRUBICIN (E) AND DOCETAXEL (T) AS FIRST LINE CHEMOTHERAPY IN ADVANCED BREAST-CANCER (ABC), European journal of cancer, 33, 1997, pp. 654-654
DOSE-FINDING AND PHARMACOKINETIC (PK) STUDY OF DAILY ORAL IDARUBICIN (IDA) IN METASTATIC BREAST-CANCER (MBC)
Authors: SORIO R TOFFOLI G ROBIEUX I RIMONDI G AITA P CORONA G CRIVELLARI D COLUSSI AM TUMOLO S
Citation: R. Sorio et al., DOSE-FINDING AND PHARMACOKINETIC (PK) STUDY OF DAILY ORAL IDARUBICIN (IDA) IN METASTATIC BREAST-CANCER (MBC), European journal of cancer, 33, 1997, pp. 1136-1136
PHARMACOKINETICS AND TOLERANCE OF VINORELBINE IN ELDERLY PATIENTS WITH METASTATIC BREAST-CANCER
Authors: SORIO R ROBIEUX I GALLIGIONI E FRESCHI A COLUSSI AM CRIVELLARI D SARACCHINI S MONFARDINI S
Citation: R. Sorio et al., PHARMACOKINETICS AND TOLERANCE OF VINORELBINE IN ELDERLY PATIENTS WITH METASTATIC BREAST-CANCER, European journal of cancer, 33(2), 1997, pp. 301-303
MENSTRUAL-CYCLE AND TIMING OF BREAST SURGERY IN PREMENOPAUSAL NODE-POSITIVE BREAST-CANCER - RESULTS OF THE INTERNATIONAL BREAST-CANCER STUDY-GROUP (IBCSG) TRIAL-VI
Authors: GOLDHIRSCH A GELBER RD CASTIGLIONE M ONEILL A THURLIMANN B RUDENSTAM CM LINDTNER J COLLINS J FORBES J CRIVELLARI D COATES A CAVALLI F SIMONCINI E FEY MF PAGANI O PRICE K SENN HJ
Citation: A. Goldhirsch et al., MENSTRUAL-CYCLE AND TIMING OF BREAST SURGERY IN PREMENOPAUSAL NODE-POSITIVE BREAST-CANCER - RESULTS OF THE INTERNATIONAL BREAST-CANCER STUDY-GROUP (IBCSG) TRIAL-VI, Annals of oncology, 8(8), 1997, pp. 751-756
EFFECTIVENESS OF ADJUVANT CHEMOTHERAPY IN COMBINATION WITH TAMOXIFEN FOR NODE-POSITIVE POSTMENOPAUSAL BREAST-CANCER PATIENTS
Authors: CASTIGLIONEGERTSCH M GOLDHIRSCH A GUSTERSON B BETTELHEIM R REED R GUSSET H GEISER K HURNY C BERNHARD J HANGARTNER A MAIBACH R PEDOWSKI R GELBER R PRICE K PETERSON H ZELEN M ISLEY M HINKLE R KAY RG HOLDAWAY IM HARVEY VJ JAGUSCH MF NEAVE L MASON BM EVANS B BENJAMIN CS CARTER JF GILLMAN JC MACK D BENSONCOOPER D MONFARDINI S GALLIGIONI E CRIVELLARI D BUONADONNA A MASSARUT S ROSSI C CANDIANI E CARBONE A VOLPE R TROVO MG RONCADIN M SANTINI GF VILLALTA D CORAN F MORASSUT S MARINI G SIMONCINI E MARPICATI P ZANIBONI A SARTORI U BARNI A CERUTTI L ALGHISI A RAFFAGLIO E GARATTINI MP ALBERTINI A GRIGOLATO F MORASSI L BERGONZINI R LAURIOLA C GUDGEON A DENT DM TILTMAN A HACKING A DOWDLE E STEYNOR P TOOP J SCHNURCH HG MOSNY D BENDER HG BOJAR H VERONESI A FOLADORE S PAMICH G BIANCHI G TORRETTA A RUDENSTAM CM WALLGREN A PERSSON S MATTSSON J CAHLIN E HAFSTROM LO HOLMBERG S HULTBORN R COLLDAHLJADERSTROM G GUSTAVSSON B CARLSSON G IVARSSON L THOREN O RUUSVIK O NICKLASSON LG DAHLIN S KARLSSON G LINDBERG B SUNDBACK A BERGEGARDH S SALANDER H ANDERSSON C HESSMAN Y NELZEN O HEIDEMAN M RAMHULT T SVENSSON JH LIDBERG P BJORK S LINDTNER J ERZEN D CERAR O STABUC B GOLOUH R LAMOVEC J SEBEK S KRAMBERGER M VRHOVEC I CORTESFUNES H MARTINEZTELLO F MENDIOLA C CRUZVIGO F LARRODERA ML SIERRA A MIRANDA P ALONSO S COLLINS J SNYDER R GREGORY P BURAS WI GREEN M GALE T HENDERSON M HART S NEIL S KITCHEN P LOVELL R MCLENNAN R REED R RUSSELL I SCHWARZ M BASSER R ROBERTSON A GILL P CARTER ML MALYCHA P YEOH E WARD G LEONG ASY LOMMAXSMITH J HOOSFALL D DANGELO R BYRNE M VANHAZEL G DEWAR J BUCK M SHEINER HJ INGRAM D STERRETT G HAHNEL R FORBES JF STEWARD J DARBAR SW BISHOP JM SIMMS B ZIOGAS V TATTERSALL MHN COATES A NIESCHE F WEST R RENWICK S DONOVAN J DUVAL P SIMES RJ NG A GLENN D NORTH RA BEITH J OCONNOR RG RICE M STEVENS G FEY M BARTH A DREHER E ISENSCHMID M SCHNEIDER H BUSER K LUDIN J LUTHI JM ALTERMATT HJ LAISSUE JA MARKWALDER R BURGI H SENN HJ THURLIMANN B JUNGI WF MORANT R OEHLSCHLEGEL C HARDMEIER T LUSCHER K RIES G TOPFER M LORENZ U BENZ D SCHILTKNECHT O SPATI B SCHMID L CAVALLI F SESSA C BRONZ L MARTINELLI G MULLER W LUSCIETI P PASSEGA E PEDRINIS E REY P MARTINOLI S SPINELLI A GALFETTI MA LOMBARDI A PEDRAZZINI A LOSA G VARINI M GINIER M HERRMANN R HARDER JF LAFFER U ALMENDRAL AC EPPENBERGER U TORHORST J SIEGENTHALER P PIGUET D BARRELET V BAUMANN RP JOSS R SAUTER C METZGER U ENGELER V HALLER U KOCHLI O LEYVRAZ S PEREY L ANANI P GOMEZ F MIRIMANOFF RO CHAPUIS G DEGRANDI P REYMOND P ALBERTO P SCHAFER P KRAUER F FORNI M AAPRO M EGELI R MEGEVAND R JACOTDESCOMBES E SCHINDLER A NOSEDA G WEBER W LEHMANN W
Citation: M. Castiglionegertsch et al., EFFECTIVENESS OF ADJUVANT CHEMOTHERAPY IN COMBINATION WITH TAMOXIFEN FOR NODE-POSITIVE POSTMENOPAUSAL BREAST-CANCER PATIENTS, Journal of clinical oncology, 15(4), 1997, pp. 1385-1394
HIGH-DOSE EPIRUBICIN IN LOCALLY ADVANCED OPERABLE NONINFLAMMATORY BREAST-CANCER - A FEASIBILITY TRIAL
Authors: CRIVELLARI D BUONADONNA A SACCO C BIDOLI E CANDIANI E MASSARUT S RONCADIN M ROSSI C GALLIGIONI E
Citation: D. Crivellari et al., HIGH-DOSE EPIRUBICIN IN LOCALLY ADVANCED OPERABLE NONINFLAMMATORY BREAST-CANCER - A FEASIBILITY TRIAL, Tumori, 83(3), 1997, pp. 656-660
VINORELBINE TREATMENT OF ADVANCED NONSMALL CELL LUNG-CANCER WITH SPECIAL EMPHASIS ON ELDERLY PATIENTS
Authors: VERONESI A CRIVELLARI D MAGRI MD CARTEI G MANSUTTI M FOLADORE S MONFARDINI S
Citation: A. Veronesi et al., VINORELBINE TREATMENT OF ADVANCED NONSMALL CELL LUNG-CANCER WITH SPECIAL EMPHASIS ON ELDERLY PATIENTS, European journal of cancer, 32A(10), 1996, pp. 1809-1811
IMPACT OF ADJUVANT THERAPY ON QUALITY-OF-LIFE IN WOMEN WITH NODE-POSITIVE OPERABLE BREAST-CANCER
Authors: HURNY C BERNHARD J COATES AS CASTIGLIONEGERTSCH M PETERSON HF GELBER RD FORBES JF RUDENSTAM CM SIMONCINI E CRIVELLARI D GOLDHIRSCH A SENN HJ
Citation: C. Hurny et al., IMPACT OF ADJUVANT THERAPY ON QUALITY-OF-LIFE IN WOMEN WITH NODE-POSITIVE OPERABLE BREAST-CANCER, Lancet, 347(9011), 1996, pp. 1279-1284
ADJUVANT IMMUNOTHERAPY TREATMENT OF RENAL-CARCINOMA PATIENTS WITH AUTOLOGOUS TUMOR-CELLS AND BACILLUS-CALMETTE-GUERIN - 5-YEAR RESULTS OF APROSPECTIVE RANDOMIZED STUDY
Authors: GALLIGIONI E QUAIA M MERLO A CARBONE A SPADA A FAVARO D SANTAROSA M SACCO C TALAMINI R FRANCINI M CRIVELLARI D DIDONNA D MAZZA G VIGGIANO G GALASSI P PANIZZO R CARMIGNANI G FIACCAVENTO G
Citation: E. Galligioni et al., ADJUVANT IMMUNOTHERAPY TREATMENT OF RENAL-CARCINOMA PATIENTS WITH AUTOLOGOUS TUMOR-CELLS AND BACILLUS-CALMETTE-GUERIN - 5-YEAR RESULTS OF APROSPECTIVE RANDOMIZED STUDY, Cancer, 77(12), 1996, pp. 2560-2566
ROUTINE TESTS DURING FOLLOW-UP OF PATIENTS AFTER PRIMARY-TREATMENT FOR OPERABLE BREAST-CANCER
Authors: CRIVELLARI D PRICE KN HAGEN M GOLDHIRSCH A GELBER RD CASTIGLIONE M COATES AS RUDENSTAM CM COLLINS J LINDTNER J CORTESFUNES H GUDGEON A SIMONCINI E BYRNE M SCHNURCH HG FEY M TATTERSALL MHN FORBES JF CAVALLI F SENN HJ
Citation: D. Crivellari et al., ROUTINE TESTS DURING FOLLOW-UP OF PATIENTS AFTER PRIMARY-TREATMENT FOR OPERABLE BREAST-CANCER, Annals of oncology, 6(8), 1995, pp. 769-776
SURVIVAL AFTER TREATMENT OF ADVANCED RENAL-CELL CARCINOMA (RCC) WITH HIGH-DOSE INTERLEUKIN-2 (RIL-2) OR VINBLASTINE (VLB)
Authors: SORIO R GALLIGIONI E CRIVELLARI D TALAMINI R MONFARDINI S
Citation: R. Sorio et al., SURVIVAL AFTER TREATMENT OF ADVANCED RENAL-CELL CARCINOMA (RCC) WITH HIGH-DOSE INTERLEUKIN-2 (RIL-2) OR VINBLASTINE (VLB), Annals of oncology, 6(3), 1995, pp. 306-307
GASTRIC-CANCER WITH BONE-MARROW INVASION AT PRESENTATION - CASE-REPORT AND REVIEW OF THE LITERATURE
Authors: CRIVELLARI D CARBONE A SIGON R BUONADONNA A CANNIZZARO R SORIO R ROSSI C MONFARDINI S
Citation: D. Crivellari et al., GASTRIC-CANCER WITH BONE-MARROW INVASION AT PRESENTATION - CASE-REPORT AND REVIEW OF THE LITERATURE, Tumori, 81(1), 1995, pp. 74-76
QUANTITATIVE LIVER-FUNCTION BY MONOETHYLGLYCINEXYLIDIDE (MEGX) TEST IN LIVER METASTASES
Authors: CANNIZZARO R ROBIEUX L SORIO R BORSATTI E CIMITAN M DEAPOLLONIA L BORTOLUZZI F TUMOLO S CRIVELLARI D VALENTINI M
Citation: R. Cannizzaro et al., QUANTITATIVE LIVER-FUNCTION BY MONOETHYLGLYCINEXYLIDIDE (MEGX) TEST IN LIVER METASTASES, Gastroenterology, 108(4), 1995, pp. 454-454
CORRELATION BETWEEN THE QUANTITATIVE LIVER-FUNCTION TEST MEGX AND VINORELBINE CLEARANCE IN PATIENTS WITH BREAST-CANCER
Authors: CANNIZZARO R ROBIEUX I SORIO R BORSATTI E FRESCHI A TUMOLO S CRIVELLARI D MONFARDINI S VALENTINI M
Citation: R. Cannizzaro et al., CORRELATION BETWEEN THE QUANTITATIVE LIVER-FUNCTION TEST MEGX AND VINORELBINE CLEARANCE IN PATIENTS WITH BREAST-CANCER, Gastroenterology, 108(4), 1995, pp. 1044-1044
CISPLATIN AND ETOPOSIDE VERSUS CYCLOPHOSPHAMIDE, EPIRUBICIN AND VINCRISTINE IN SMALL-CELL LUNG-CANCER - A RANDOMIZED STUDY
Authors: VERONESI A CARTEI G CRIVELLARI D MAGRI MD DELLAVALENTINA M FOLADORE S TROVO MG NASCIMBEN O SIBAU A TALAMINI R MONFARDINI S
Citation: A. Veronesi et al., CISPLATIN AND ETOPOSIDE VERSUS CYCLOPHOSPHAMIDE, EPIRUBICIN AND VINCRISTINE IN SMALL-CELL LUNG-CANCER - A RANDOMIZED STUDY, European journal of cancer, 30A(10), 1994, pp. 1474-1478
CISPLATIN AND ETOPOSIDE VERSUS CYCLOPHOSPHAMIDE, EPIRUBICIN AND VINCRISTINE IN SMALL-CELL LUNG-CANCER - A RANDOMIZED STUDY
Authors: VERONESI A CARTEI G CRIVELLARI D MAGRI MD DELLAVALENTINA M FOLADORE S TROVO MG NASCIMBEN O SIBAU A TALAMINI R MONFARDINI S
Citation: A. Veronesi et al., CISPLATIN AND ETOPOSIDE VERSUS CYCLOPHOSPHAMIDE, EPIRUBICIN AND VINCRISTINE IN SMALL-CELL LUNG-CANCER - A RANDOMIZED STUDY, European journal of cancer, 30A(10), 1994, pp. 1474-1478
PROSPECTIVE RANDOMIZED TRIAL COMPARING FLUOROURACIL VERSUS DOXIFLURIDINE FOR THE TREATMENT OF ADVANCED COLORECTAL-CANCER
Authors: BAJETTA E COLLEONI M ROSSO R SOBRERO A AMADORI D COMELLA G MARANGOLO M SCANNI A LORUSSO V CALABRESI F BONSIGNORI M CRIVELLARI D PASQUINI E BRUZZI P REPETTO M CRISCUOLO D
Citation: E. Bajetta et al., PROSPECTIVE RANDOMIZED TRIAL COMPARING FLUOROURACIL VERSUS DOXIFLURIDINE FOR THE TREATMENT OF ADVANCED COLORECTAL-CANCER, European journal of cancer, 29A(12), 1993, pp. 1658-1663
EPIRUBICIN AND IFOSFAMIDE IN ADVANCED SOFT-TISSUE SARCOMAS
Authors: FRUSTACI S FOLADORE S BUONADONNA A DEPAOLI A CRIVELLARI D CARBONE A SORIO R MORASSUT S MONFARDINI S
Citation: S. Frustaci et al., EPIRUBICIN AND IFOSFAMIDE IN ADVANCED SOFT-TISSUE SARCOMAS, Annals of oncology, 4(8), 1993, pp. 669-672
Risultati: 1-25 |